14-23118629-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001805.4(CEBPE):​c.463C>A​(p.Leu155Met) variant causes a missense change. The variant allele was found at a frequency of 0.00715 in 1,611,416 control chromosomes in the GnomAD database, including 49 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0053 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0073 ( 44 hom. )

Consequence

CEBPE
NM_001805.4 missense

Scores

8
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 5.91

Publications

12 publications found
Variant links:
Genes affected
CEBPE (HGNC:1836): (CCAAT enhancer binding protein epsilon) The protein encoded by this gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related protein CEBP-delta. The encoded protein may be essential for terminal differentiation and functional maturation of committed granulocyte progenitor cells. Mutations in this gene have been associated with Specific Granule Deficiency, a rare congenital disorder. Multiple variants of this gene have been described, but the full-length nature of only one has been determined. [provided by RefSeq, Jul 2008]
CEBPE Gene-Disease associations (from GenCC):
  • specific granule deficiency 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • specific granule deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009663373).
BP6
Variant 14-23118629-G-T is Benign according to our data. Variant chr14-23118629-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 530670.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00534 (814/152328) while in subpopulation NFE AF = 0.00815 (554/68016). AF 95% confidence interval is 0.00758. There are 5 homozygotes in GnomAd4. There are 413 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001805.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPE
NM_001805.4
MANE Select
c.463C>Ap.Leu155Met
missense
Exon 1 of 2NP_001796.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPE
ENST00000206513.6
TSL:1 MANE Select
c.463C>Ap.Leu155Met
missense
Exon 1 of 2ENSP00000206513.5
CEBPE
ENST00000696121.1
n.432C>A
non_coding_transcript_exon
Exon 2 of 3
CEBPE
ENST00000696122.1
n.209C>A
non_coding_transcript_exon
Exon 2 of 3

Frequencies

GnomAD3 genomes
AF:
0.00535
AC:
814
AN:
152210
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00130
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0153
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00814
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00606
AC:
1490
AN:
245940
AF XY:
0.00586
show subpopulations
Gnomad AFR exome
AF:
0.00128
Gnomad AMR exome
AF:
0.00113
Gnomad ASJ exome
AF:
0.000904
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0176
Gnomad NFE exome
AF:
0.00936
Gnomad OTH exome
AF:
0.00546
GnomAD4 exome
AF:
0.00733
AC:
10700
AN:
1459088
Hom.:
44
Cov.:
32
AF XY:
0.00715
AC XY:
5190
AN XY:
726022
show subpopulations
African (AFR)
AF:
0.000896
AC:
30
AN:
33478
American (AMR)
AF:
0.00105
AC:
47
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.000498
AC:
13
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86228
European-Finnish (FIN)
AF:
0.0182
AC:
929
AN:
50910
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00839
AC:
9328
AN:
1111892
Other (OTH)
AF:
0.00570
AC:
344
AN:
60326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
670
1340
2010
2680
3350
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00534
AC:
814
AN:
152328
Hom.:
5
Cov.:
32
AF XY:
0.00554
AC XY:
413
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00130
AC:
54
AN:
41584
American (AMR)
AF:
0.00189
AC:
29
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.0153
AC:
162
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00815
AC:
554
AN:
68016
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
46
91
137
182
228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00714
Hom.:
24
Bravo
AF:
0.00413
TwinsUK
AF:
0.00674
AC:
25
ALSPAC
AF:
0.00778
AC:
30
ESP6500AA
AF:
0.00182
AC:
8
ESP6500EA
AF:
0.00779
AC:
67
ExAC
AF:
0.00647
AC:
785
EpiCase
AF:
0.00665
EpiControl
AF:
0.00711

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CEBPE: BS2

Specific granule deficiency Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CEBPE-related disorder Benign:1
Nov 16, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.41
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.34
T
Eigen
Uncertain
0.55
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.64
T
MetaRNN
Benign
0.0097
T
MetaSVM
Benign
-0.54
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
5.9
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-0.80
N
REVEL
Benign
0.11
Sift
Uncertain
0.011
D
Sift4G
Uncertain
0.035
D
Polyphen
1.0
D
Vest4
0.35
MVP
0.65
MPC
0.60
ClinPred
0.019
T
GERP RS
4.3
Varity_R
0.25
gMVP
0.38
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141903485; hg19: chr14-23587838; COSMIC: COSV99079624; API